Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infections × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 229 Carcinoma, Non-Small-Cell Lung 161 Prostatic Neoplasms 147 Stomach Neoplasms 88 Lung Neoplasms 77 Squamous Cell Carcinoma of Head and Neck 61 Head and Neck Neoplasms 53 Esophageal Neoplasms 50 Neoplasms 37 Nasopharyngeal Carcinoma 29 Pancreatic Neoplasms 27 Neoplasm Metastasis 26 Sarcoma 24 Ovarian Neoplasms 23 Urinary Bladder Neoplasms 21 Triple Negative Breast Neoplasms 20 Adenocarcinoma 17 Carcinoma, Squamous Cell 16 Adenocarcinoma Of Esophagus 15 Esophageal Squamous Cell Carcinoma 13 Carcinoma, Transitional Cell 12 Carcinoma, Ovarian Epithelial 12 Unspecified Adult Solid Tumor, Protocol Specific 11 Breast Neoplasms, Male 11 Salivary Gland Neoplasms 10 Adenocarcinoma of Lung 9 Uterine Cervical Neoplasms 8 Small Cell Lung Carcinoma 8 Melanoma 8 Leiomyosarcoma 8

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 6 Fluconazole 3 Antibiotic Prophylaxis 3 gamma-Globulins 2 Vancomycin 2 Ribavirin 2 Immunoglobulins, Intravenous 2 Fosfomycin 2 Daptomycin 2 Amoxicillin-Potassium Clavulanate Combination 2 ziprasidone 1 tocilizumab 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1 lime 1 idecabtagene vicleucel 1 golimumab 1 gilteritinib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 fludarabine phosphate 1 fish oil triglycerides 1 avdoralimab 1 Zolpidem 1 X-Rays 1 Whole-Body Irradiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04324346 2021-03-18

PICC&PAC

Swedish Red Cross University College

Phase NA Completed

Infections, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡